Preferred Label : betamethasone-17,21-dipropionate;
MeSH note : may also contain chlorocresol (UD 25:22R);
CISMeF synonym : augmented betamethasone dipropionate; beloderm; betamethasone propionate; diprolene; diprosone; maxivate;
MeSH synonym : betamethasone dipropionate;
MeSH Related Number : 5593-20-4;
Registry Number MeSH : 5593-20-4;
Is substance : O;
UNII : 826Y60901U;
InChIKey : CIWBQSYVNNPZIQ-XYWKZLDCSA-N;
Origin ID : C011175;
UMLS CUI : C0053523;
CISMeF manual mappings
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3488641/fr/closalis-calcipotriol/betamethasone-psoriasis
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
adult
calcipotriol, combinations
administration, cutaneous
ointments
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1
gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment
(clinical drug)
evaluation of the transparency committee
psoriasis
---
https://www.has-sante.fr/jcms/p_3389403/fr/wynzora-calcipotriol/betamethasone-psoriasis
2022
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
ointments
administration, cutaneous
calcipotriene
betamethasone dipropionate, calcipotriol drug combination
betamethasone
betamethasone-17,21-dipropionate
anti-inflammatory agents
calcipotriol, combinations
dermatologic agents
scalp dermatoses
Psoriasis of scalp (disorder)
Product containing only betamethasone and calcipotriol in cutaneous dose form (medicinal
product form)
adult
evaluation of the transparency committee
psoriasis
---
https://www.has-sante.fr/jcms/p_3262265
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
betamethasone dipropionate, calcipotriol drug combination
betamethasone-17,21-dipropionate
administration, cutaneous
evaluation of the transparency committee
---
https://www.has-sante.fr/jcms/p_3262271/fr/enstilar-calcipotriol-betamethasone
2021
false
false
false
France
betamethasone-17,21-dipropionate
treatment outcome
insurance, health, reimbursement
administration, cutaneous
calcipotriol, combinations
anti-inflammatory agents
glucocorticoids
adult
psoriasis
evaluation of the transparency committee
calcipotriene
betamethasone
calcitriol
---
https://www.has-sante.fr/portail/jcms/c_2899210/fr/diprosalic
2019
false
France
French
evaluation of the transparency committee
corticosteroid therapy
betamethasone dipropionate, salicylic acid drug combination
administration, cutaneous
salicylic acid
betamethasone
anti-inflammatory agents
betamethasone-17,21-dipropionate
psoriasis
lichenoid eruptions
dermatitis, seborrheic
betamethasone
treatment outcome
administration, topical
scalp dermatoses
adult
insurance, health, reimbursement
drug combinations
salicylates
---
https://www.has-sante.fr/portail/jcms/c_2803498/fr/enstilar
2017
false
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
treatment outcome
insurance, health, reimbursement
administration, cutaneous
drug combinations
psoriasis
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
guidelines for drug use
dermatologic agents
anti-inflammatory agents
glucocorticoids
Topical Foam Dosage Form
adult
betamethasone
calcitriol
calcitriol
calcitriol
betamethasone
betamethasone
---
http://www.has-sante.fr/portail/jcms/c_2040751/fr/daivobet
2015
true
France
French
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee
drug combinations
---
http://www.has-sante.fr/portail/jcms/c_1743051/fr/xamiol
http://www.has-sante.fr/portail/jcms/c_778871/xamiol
2014
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
administration, topical
insurance, health, reimbursement
treatment outcome
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
psoriasis
scalp dermatoses
adult
meta-analysis as topic
glucocorticoids
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations
---
http://www.has-sante.fr/portail/jcms/c_1743048/fr/daivobet
http://www.has-sante.fr/portail/jcms/c_968478/daivobet
2014
false
France
French
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1215839/diprosalic
http://www.has-sante.fr/portail/jcms/c_724454/diprosalic
http://www.has-sante.fr/portail/jcms/c_1649710/fr/diprosalic
http://www.has-sante.fr/portail/jcms/c_1649709/fr/diprosalic-18092013-avis-ct13017
2013
France
French
evaluation of the transparency committee
corticosteroid therapy
betamethasone dipropionate, salicylic acid drug combination
administration, cutaneous
salicylic acid
betamethasone
anti-inflammatory agents
betamethasone-17,21-dipropionate
psoriasis
lichenoid eruptions
dermatitis, seborrheic
betamethasone
treatment outcome
administration, topical
scalp dermatoses
adult
insurance, health, reimbursement
---
http://www.has-sante.fr/portail/jcms/c_1098681/celestene-diprosone-diprolene-diprostene
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-09/celestene_diprostene_diprolene_diprosone_-_ct7408.pdf
2011
France
French
evaluation of the transparency committee
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
anti-inflammatory agents
administration, oral
administration, cutaneous
injections
betamethasone
betamethasone
betamethasone acetate phosphate
betamethasone sodium phosphate
glucocorticoids
betamethasone
insurance, health, reimbursement
drug combinations
betamethasone-17,21-dipropionate
betamethasone
---
http://www.lecrat.eu/?s=B%C3%A9tam%C3%A9thasone
2011
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
glucocorticoids
pregnancy
betamethasone
infant, newborn
breast feeding
betamethasone
betamethasone sodium phosphate
betamethasone dipropionate, salicylic acid drug combination
betamethasone-17,21-dipropionate
betamethasone
salicylic acid
drug combinations
drug information
---
http://www.has-sante.fr/portail/jcms/c_819524/xamiol-calcipotriol-et-betamethasone-en-application-locale
http://www.has-sante.fr/portail/jcms/c_779196/xamiol-ct-6219
2009
France
French
betamethasone dipropionate, calcipotriol drug combination
calcitriol
drug combinations
betamethasone
psoriasis
scalp dermatoses
calcipotriene
betamethasone-17,21-dipropionate
calcipotriol, combinations
evaluation of the transparency committee
guidelines for drug use
---
